|
EFTUD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62492241884138E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.40970029988341E-10 |
| Normal-vs-Stage2 |
2.542200E-03 |
| Normal-vs-Stage3 |
3.412300E-04 |
| Normal-vs-Stage4 |
1.478030E-02 |
| Stage1-vs-Stage2 |
4.576800E-01 |
| Stage1-vs-Stage3 |
2.542400E-01 |
| Stage1-vs-Stage4 |
3.788800E-01 |
| Stage2-vs-Stage3 |
8.475800E-01 |
| Stage2-vs-Stage4 |
8.084600E-01 |
| Stage3-vs-Stage4 |
9.307200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.66053886991358E-15 |
| Normal-vs-AfricanAmerican |
8.60969999960659E-07 |
| Normal-vs-Asian |
1.303970E-01 |
| Caucasian-vs-AfricanAmerican |
1.394610E-01 |
| Caucasian-vs-Asian |
7.141800E-01 |
| AfricanAmerican-vs-Asian |
3.455400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.32682753672952E-12 |
| Normal-vs-Female |
7.0983219302434E-12 |
| Male-vs-Female |
5.563300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.87009999999388E-05 |
| Normal-vs-Extreme_Weight |
2.57019999949648E-07 |
| Normal-vs-Obese |
1.39479999772263E-08 |
| Normal-vs-Extreme_Obese |
2.188600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.357000E-01 |
| Normal_Weight-vs-Obese |
7.747200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.880000E-01 |
| Extreme_Weight-vs-Obese |
3.671000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.216000E-01 |
| Obese-vs-Extreme_Obese |
4.239600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.5937000000551E-06 |
| Normal-vs-Age(41-60Yrs) |
9.10382880192628E-15 |
| Normal-vs-Age(61-80Yrs) |
5.42900002731272E-09 |
| Normal-vs-Age(81-100Yrs) |
5.327600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.884270E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.236800E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.415300E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.333600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.258300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.680000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.99440505513849E-15 |
| Normal-VS-Type2 PRCC |
2.40499999999422E-05 |
| Normal-VS-KIRP CIMP |
2.899100E-03 |
| Normal-VS-Unclassified PRCC |
2.20309999999779E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.901600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.511720E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.468600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.024500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.116400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.769970E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.017130E-04 |
| Normal-vs-N1 |
2.208300E-04 |
| Normal-vs-N2 |
1.609020E-01 |
| N0-vs-N1 |
6.778100E-02 |
| N0-vs-N2 |
6.150000E-02 |
| N1-vs-N2 |
4.481400E-01 |
|
|
